10X Genomics(TXG)

PLEASANTON, CABiotechnology4 H-1B visas (FY2023)

Focus: 10X Genomics is a public genomics platform company headquartered in Pleasanton, CA, providing sequencing and analysis tools for research and clinical applications across oncology, neurology, and ophthalmology.

Neurology Oncology Ophthalmology

Profile data last refreshed 38m ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

42+1 this month

Stable — net +1 jobs in 30d

14 added, 13 removed. Backfill posture.

3 recent layoff filings (12 mo) — 93 affected

5/6/2025 — CA · 3 affected · Layoff Amendment
5/6/2025 — 6210 Stoneridge Mall Road Pleasanton CA 94588, CA · 2 affected · Layoff
5/6/2025 — 6230 Stoneridge Mall Road Pleasanton CA 94588, CA · 88 affected · Layoff

Source: state DOL filings via Big Local News

Should You Work at 10X Genomics?

AI assessment

Attractive for commercial, IT, and operations professionals seeking growth-stage biotech with platform upside; risky for research scientists given thin R&D hiring and ongoing cash burn.

Why Work Here

High R&D intensity (44%) signals investment in innovation and technical career development opportunities
Commercial hiring surge (14 of 41 open roles) indicates market expansion and sales trajectory growth

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$619M

Recent News · 10X Genomics(3)

FinancialSEC 8-K

Mar 9, 2026

8-K Filing: Xilio Therapeutics, Inc. (XLO) (CIK 0001840233) — EX-99.1

EX-99.1

Help build intelligence for 10X Genomics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Public company status with $619M FY2025 revenue provides stability and equity upside potential

Watch Out For

Burning $255M net loss in FY2025 on $619M revenue suggests path to profitability remains uncertain
Only 2 R&D roles open despite 44% R&D spend indicates limited entry points for research scientists

Generated by Claude from 10X Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

FinancialSEC 8-K

Feb 25, 2026

8-K Filing: CareDx, Inc. (CDNA) (CIK 0001217234) — EX-99.1

EX-99.1

Interview Prep Quick Facts

H-1B (2023): 4 approvals

Publications: 25 in PubMed

SEC Filings: 2 available

Open Roles: 42 active jobs

Financials (FY2025)

Revenue

$619M20%

R&D Spend

$270M(44%)2%

Net Income

-$255M

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

80%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

WARN Act Layoff Notices (3)

2025-05-06

3 employees affected— CA

source

2025-05-06

2 employees affected— 6210 Stoneridge Mall Road Pleasanton CA 94588, CA

source

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins.

Nature neuroscience

2026

PMID:41566006

Publisher Correction: Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins.

2025-05-06

88 employees affected— 6230 Stoneridge Mall Road Pleasanton CA 94588, CA

source

Source: state DOL filings, aggregated via Big Local News

No visible regulatory or workforce restructuring warnings; primary risk is cash burn rate if revenue growth stalls.

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

10X Genomics(TXG)

Should You Work at 10X Genomics?

Why Work Here

Recent News · 10X Genomics(3)

Watch Out For

Open Jobs (42)

Production Technician (TEMP)

P-5010 Scientist II, Reagents Sustaining and Applications

Xenium Sales Executive

Clinical Laboratory Scientist, (General Supervisor)

Clinical Laboratory Scientist, (Technical Supervisor)

Senior Data Platform Engineer

Supply/Production Planner (Contractor)

Director, Operations and R&D Finance

Director, Human Resources Business Partner, R&D

Mechanical Engineering Intern

Senior Product Manager, Growth

Senior Product Manager, Sales Systems

Market Development Manager: Biopharma & Academia (Translational Research)

Sr. Program Manager

Field Application Scientist, Chicago

Sales Development Representative, New York Area

Senior Buyer-Indirect (TEMP)

Sr. Systems Engineer

Staff Mechanical Engineer, Consumables

Field Service Engineer – Japan

Field Service Engineer - Japan

Global Commercial Education Manager

Associate Director, Commercial Contracts

Sales Development Representative, West

Sr. Mechanical Engineer

Financials (FY2025)

Hiring Trend

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (3)

Research Publications(10)